Exploration of cardiac biomarkers to decline mortality in COVID-19 Patients


AUTHORS: Sonila Khan, Rabia Yaqoob




Volume:1

Issue: 4

Page: 37-42


Received: 01-Mar-2021

Accepted: 09-Mar-2021


ABSTRACT:COVID 19 disease is caused by SARS CoV-2 had been started from Wuhan, a city of China and affected hundreds of countries has no therapeutic agents known for the treatment. [2] The mortality rate of disease is high with the patients with pre-existing cardiovascular diseases. In some cases, COVID 19 is associated with induction of acute COVID 19 cardiovascular syndromes. The mortality risks of disease can be lessened by early detection of cardiovascular diseases and myocardial injuries by elevated level of cardiac biomarkers more specifically cardiac troponin I (cTnI) and B type natriuretic peptides (BNP)[4] and N terminal pro BNP NT pro BNP) [7]. Virus enters the cardiac cells by specific binding with spike proteins and caused increase destruction of myocardial cells and leading toward the release of specific cardiac troponin in the blood stream.


SUBMISSION LAST DATE

15 JUN 2021

CALL FOR PAPER


JUN 2021 Volume 1, Issue 7

PROCESSING FEES

Publication fees of papers in IJMRE is:
Indian Author: 1000 Rs
International Author : 20$

No fees required for developing countries with low income countries, according to the World Bank Country classification by Income level.
click here
MANUSCRIPT TEMPLATE

Requested to All the authors, send original research results according to the given template. Doc & PDF

PUBLICATIONAL LANGUAGE

English


PUBLICATION FREQUENCY

12 Issues per year

ARCHIVES
JOURNAL INDEXING

we'll one over 30 Years of experience you always the best guidance

Contact Us